Northeastern University

Perform hands-on research in an

NCI-funded lab

Perform hands-on research in an

NCI-funded lab

0
Trainees
0
Publications
0
Laboratories
0
Awards
0
Higher Degrees

Our Current Trainees

Health Sciences, '24

Using Gapmers in Multiple Myeloma to Increase Immune Response

Biochemistry, '24

Lipid Nanoparticles for the Delivery of Tumor Suppressor mRNA

Biology, '24

Localized Delivery of PARP Inhibitors for the Treatment of Ovarian Cancer

Biology, '25

Early Diagnosis of Acute Kidney Injury

Health Sciences, '24

Screening for Multiple Myeloma Precursors in a High-Risk Population using Mass Spectrometry

Behavioral Neuroscience, '25

Diffuse Intrinsic Pontine Glioma (DIPG) and Brainstem Tumors in Pediatric Patients

Biochemistry, '25

Multiplexed Digital ELISA Assay for Early Pancreatic Cancer Detection

What if you could buy a cancer test at your local store, take it to the privacy of your own home, and get the results immediately?  This vision inspired me to develop a cervical cancer screening test with CaNCURE. A year later, I returned to the same lab to field test my device in Botswana…

 

Victoria D’Agostino, ’19

PhD Candidate, Ctr for Global Women’s Health Technologies, Duke University

Past Trainees

Behavioral Neuroscience, '25

Sustained Release Talazoparid for Treatment of BRCA1 Deficient Breast Cancer

Public Health & Health Science, '24

Understanding and Overcoming Resistance to PARP Inhibitors in Ovarian Cancer Patients

Biochemistry, '24

Characterizing Resistance to Immunogenic Cell Death in the Treatment Multiple Myeloma with Bortezomib

Biochemistry, '24

Transcriptional Targets of p53 in Merkel Cell Carcinoma (MCC)

Biochemistry, '24

Minor Histocompatibility Antigen Validation

Cell & Mollecular Biology, '24

A Dual Function Antibody Conjugate for Tumor Targeted Molecular Imaging and Treatment

Bioengineering & Biochemistry, '24

Liver-mediated epigenetic reprogramming of CRC primary tumor drives metastasis

Bioengineering and Biochemistry, '24

Renal Imaging using a Ferumoxytol Nanoparticle Contrast Agent

Behavioral Neuroscience, '24

Nano-formulations and Sustained Delivery of Combination Therapy of TLZ with CER or ALP to Overcome PARPi Resistance for Ovarian Cancer Treatment

Data Science & Biochemistry, '24

Evaluating the Oncogene-specific Dependency of TIMM17A and MTCH2 in MYC-amplified Cancers

Cell & Molecular Biology, '23

Long-term Sustained Release of Ovarian Cancer Therapy Via a Biodegradable Implant

Biochemistry, '23

MN-miR710 as a Therapy for Preventing Metastasis in Human Cancers​

Biochemistry, '23

SHMT2 and CDK4 in Metastatic Triple Negative Breast Cancer​

Cell & Molecular Biology, '23

Studying the Anti-Tumor Effects of Exercise in Breast Cancer

Behavioral Neuroscience, '23

Imaging Methodologies: Raman Spectroscopy

Biology, '23

Tracking Nanodrug Distribution in Lung Tissue​

Biology, '23

Hydrogel Sustained 177Lu-labeled Ferumoxytol Nanoparticles (177Lu-FH) for Intratumoral Injection Radionuclide Therapy

Bioengineering, '23

Gadolinium-Based Nanoparticles for Lung Cancer Radiation Dosage Enhancement

Cellular and Molecular Biology, '23

Molecular Imaging for Detection of Gastrointestinal and Pancreatic Cancers

Behavioral Neuroscience, '23

Effectiveness of Ferumoxytol for the Detection of Pancreatic and Hepatic Masses in CT and MR Imaging

Biochemistry, '23

Developing Nanoparticle Formulations to Enhance Radiotherapy of Human Lung Cancer Cells​

Health Sciences, '23

Establishing Ferumoxytol as a Clinically Relevant Alternative Contrast Agent​

Health Science, '23

Rapid Hormone Receptor Status Classification Based on Molecular Profiling and Imaging of Breast Cancer Tissue

Biochemistry, '23

RPS15 and TP53 co-mutation drives B cell malignancy in CLL